×

Member Login

Home / Categories / By country / America / North America / USA / HCP - USA

Download available for users with full-size access enabled

RisperdalConsta - solid footing

For many patients with schizophrenia
Gaps in medication can compromise their progress

The only long-acting atypical antipsychotic

In schizophrenia
Help to keep them on solid footing-two weeks at a time

Risperdal Consta, while not guaranteed adherence, allows you to recognize and intervene when a patient misses a dose


Campaign files
Similar ads

Brand name: RisperdalConsta
Generic name/category: risperidone
Company: Janssen
Country/Market: USA, North America
Indication(s)/Category: schizophrenia
Target: Healthcare Professionals (HCP)
Tagline: none
Medium: Print ad
Size/duration: Double-page spread
Publication/Aired: Psychiatric News - January 18, 2008

To see more of this brand's ads, click here

About  Subscriptions  Contact us  YouTube  LinkedIn  Bluesky